Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.1 Description of Securities Registered Under Section 12 of the Exchange Act
- 4.14 Settlement Agreement and Release Dated December 29, 2022, Among Nano-x Imaging LTD, Nano-x Ai LTD. (Formerly Zebra Medical Vision LTD.) and Perryllion LTD
- 4.15 First Amendment to Stock Purchase Agreement Dated April 28, 2023, by and Among DR. Michael Yuz, As the Seller Representative, Nano-x Imaging, Inc. and Nano-x Imaging LTD
- 8.1 List of Subsidiaries of the Registrant
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 13.2 Certification
- 15.1 Consent of Kesselman & Kesselman, Certified Public Accountants (Isr.) a Member Firm of Pricewaterhousecoopers International Limited, Independent Registered Public Accounting Firm
- Download Excel data file
- View Excel data file
Associated NNOX transcripts
NNOX similar filings
Filing view
External links
Exhibit 13.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Annual Report on Form 20-F of Nano-X Imaging Ltd. (the “Company”) for the twelve-months ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Ran Daniel, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: May 1, 2023
By: | /s/ Erez Meltzer | |
Erez Meltzer | ||
Chief Executive Officer |